+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anaplastic Thyroid Cancer Drug"

Global Anaplastic Thyroid Cancer Drugs Market 2024-2028 - Product Thumbnail Image

Global Anaplastic Thyroid Cancer Drugs Market 2024-2028

  • Report
  • December 2023
  • 151 Pages
  • Global
From
Anaplastic Thyroid Cancer - Pipeline Insight, 2022 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Insight, 2022

  • Clinical Trials
  • May 2022
  • 60 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Anaplastic Thyroid Cancer (ATC) is a rare and aggressive form of thyroid cancer that is difficult to treat. Oncology drugs are used to treat ATC, including chemotherapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific molecules in cancer cells. Immunotherapy drugs are used to stimulate the body’s immune system to fight cancer cells. The ATC drug market is a rapidly growing segment of the oncology drug market. ATC drugs are expensive and often require multiple treatments, making them a lucrative market for drug companies. The market is expected to grow as new drugs are developed and approved for use. Companies in the ATC drug market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are developing and marketing drugs to treat ATC, as well as other forms of cancer. Show Less Read more